Appeals court temporarily blocks mail-order abortion nationwide
A U.S. appeals court has temporarily blocked the mailing of the abortion pill mifepristone nationwide. The decision stems from a lawsuit by Louisiana challenging the FDA's removal of in-person dispensing requirements. Mifepristone is used in a significant majority of abortions in the United States.
- ▪The U.S. Court of Appeals for the 5th Circuit issued the temporary block on mail-order mifepristone.
- ▪Louisiana filed the lawsuit against the FDA over its decision to eliminate in-person screening for the drug.
- ▪Mifepristone is used in nearly two-thirds of the more than 1.1 million abortions performed annually in the U.S.
- ▪The ruling is part of ongoing legal challenges following the Supreme Court's 2022 decision to overturn Roe v. Wade.
Opening excerpt (first ~120 words) tap to expand
The U.S. Court of Appeals for the 5th Circuit temporarily blocked the abortion pill mifepristone from being sold online and transported to patients through the mail. The order comes as part of litigation against the Food and Drug Administration, filed by the state of Louisiana, regarding the agency’s decision to remove in-person screening requirements for dispensing the abortion drug. Recommended Stories Radiologist Nicole Saphier replaces MAHA star Casey Means as Trump surgeon general pick CDC head Jay Bhattacharya hits back at critics over withheld COVID-19 vaccine study GOP states plan for tougher Medicaid work requirements Mail-order abortion has been a major concern in the abortion debate since the Supreme Court overturned Roe v. Wade in 2022.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Washington Examiner.
Discussion
0 commentsMore from Washington Examiner
